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Abstract
Mitochondrial potassium channels are important mediators of cell protection against stress. The mitochondrial large-
conductance ‘‘big’’ K
+ channel (mBK) mediates the evolutionarily-conserved process of anesthetic preconditioning (APC),
wherein exposure to volatile anesthetics initiates protection against ischemic injury. Despite the role of the mBK in
cardioprotection, the molecular identity of the channel remains unknown. We investigated the attributes of the mBK using
C. elegans and mouse genetic models coupled with measurements of mitochondrial K
+ transport and APC. The canonical
Ca
2+-activated BK (or ‘‘maxi-K’’) channel SLO1 was dispensable for both mitochondrial K
+ transport and APC in both
organisms. Instead, we found that the related but physiologically-distinct K
+ channel SLO2 was required, and that SLO2-
dependent mitochondrial K
+ transport was triggered directly by volatile anesthetics. In addition, a SLO2 channel activator
mimicked the protective effects of volatile anesthetics. These findings suggest that SLO2 contributes to protection from
hypoxic injury by increasing the permeability of the mitochondrial inner membrane to K
+.
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Introduction
Biological systems contain endogenous mechanisms for protection
against stress. In particular, protection against ischemia-reperfusion
(IR) injury is thought to proceed via opening of mitochondrial K
+
channels [1]. Several cardioprotective strategies require such
channels, and channel opening alone is sufficient to induce
protection [2,3]. For example, the protection by ischemic precon-
ditioning involves the mitochondrial ATP-sensitive K
+ (mKATP)
channel and activation of the channel is cardioprotective [2,3,4].
Similarly, volatile anesthetics protect the heart against IR injury, in a
phenomenon termed ‘‘anesthetic preconditioning’’ (APC) [5,6].
APC is evolutionarily conserved from C. elegans to mammals [7], and
is potentially of clinical importance [6]. The precise mechanisms of
APC remain elusive, although mitochondrial Ca
2+ activated K
+
channels have been proposed as mediators [8]. The canonical cell
surface large-conductance, ‘‘big’’ K
+ (BK) channel is coded for by
the slo-1 gene in worms and by the Kcnma1 (Slo1)g e n ei nm i c e .
Pharmacologicevidencecurrently favorsSLO1 asthemitochondrial
BK (mBK) channel necessary for cardioprotection [9,10].
However, the large-conductance K
+ channel gene family also
includes Slo2, represented by a single slo-2 gene in worms and by
two genes Kcnt1 (Slo2.2/Slack) and Kcnt2 (Slo2.1/Slick) in mice. Slo2
genes are widely expressed [11,12,13]. While a third Slo family
member, Slo3/Kcnu1, has also been identified, its expression is
restricted to mammalian spermatozoa [14]. The aim of this study
was to combine the power of C. elegans genetics with mouse heart
physiology and isolated mitochondrial assays, to investigate the
relative contribution of SLO1 and SLO2 to mBK underlying
APC. Here, we present evidence supporting an evolutionarily
conserved role for SLO2 in facilitating mitochondrial K
+ transport
leading to APC.
Methods
Full experimental details are in Supporting Information S1.
C. elegans
Strains used in this study include Bristol-N2 (wild-type, WT);
NM1968 slo-1(js379)V; LY100 slo-2(nf100)X; VC1819 slo-
2(ok2214)X; KWN193 pha-1(e2123)III, him-5(e1490)V rnyEx112
[pKT60 (partial Slo-2: mCherry) recombined in vivo with linear
WRM061CF07 fosmid, pCL1 (pha-1+)]; KWN 314 slo-2(nf100)X,
pha-1 (e2123ts)III, rnyEx112; KWN 352 pha-1(e2123)III him-
5(e1490)V, rnyEx216 [pKT111 (Pslo-2:SLO-2:GFP), pCL1 (pha-
1+)]. All mutant alleles were obtained from the C. elegans Genetic
Center and were either obtained backcrossed or were backcrossed
onto an N2-Bristol background. Single worm PCR genotyping was
used to follow the mutant alleles.
Mice
Characterization of the mBK channel was performed using
male wild-type (WT) C57BL6 mice age 6–8 weeks purchased from
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involving Slo1
-/- (KCNMA1
-/-) knockout mice were on an FVB
background [15]. Mice were genotyped by tail biopsy PCR, as
previously described [15]. Male WT and Slo1
-/- littermates age 6–
8 weeks were used in experiments.
Ethics Statement
All mice were maintained in an AAALAC-accredited pathogen-
free barrier facility with food and water available ad libitum. All
procedures were in accordance with the NIH Guide for the Care
and Use of Laboratory Animals and were approved by an
Institutional Animal Care and Use Committee (University
Committee on Animal Resources (UCAR) protocol 2010–030).
Hypoxic killing and APC of C. elegans
Experiments were performed on chronologically-synchronized
populations of young-adult animals. Briefly, adult hermaphrodites
were allowed to lay embryos for a period of two hours, and their
adult progeny were tested for the ability to be preconditioned by
2% isoflurane or 4 hours of anoxia essentially as described [7].
Isolation of mitochondria and BTC-AM loading
Mitochondria were isolated from C. elegans as previously
described [16]. Mitochondria were isolated from mouse hearts
as previously described [17]. The mitochondria were incubated
with 20 mM BTC-AM and 0.05% Pluronic F-127 for 10 min at
room temperature. The final mitochondrial pellet was suspended
in 225 ml of the respective isolation medium described in
Supporting Information S1 and stored on ice until use, within
1.5 hrs. Protein was determined by the Folin-phenol method [18].
mBK thallium flux assay (Tl
+-flux).
Tl
+ is a surrogate for K
+ and the Tl
+-flux assay is widely used in
the cellular K
+ channel field [19]. Tl
+ uptake into mitochondria
were measured using a Varian Cary Eclipse spectrofluorometer as
previously described [20] by monitoring changes in BTC
fluorescence (lex 488 nm, lem 525 nm).
Mouse Langendorff ex-vivo perfused heart
Following anesthesia with avertin, a rodent 3-lead EKG was
briefly obtained. A thoracotomy was then performed, and the
aorta cannulated in-situ and rapidly transferred to a perfusion
apparatus, as previously described [17]. The heart was perfused
with Krebs-Henseleit buffer using constant flow and exposed to
global ischemia, as detailed in Supporting Information S1.
Following experimental protocols, hearts were stained and imaged
as previously described to quantitate infarct size [21].
Reagents
All chemicals were of the highest grade available from Sigma
(St. Louis, MO) unless otherwise specified. Iberiotoxin, Char-
ybdotoxin, and Apamin were from EMD Chemicals Group
(Darmstadt, Germany); Bepridil and Paxilline were from Enzo Life
Sciences International, Inc. (Plymouth Meeting, PA); Bithionol
was from TCI America (Portland, OR); BTC-AM, Benzothiazole
coumarin acetyoxymethyl ester was from Invitrogen (Carlsbad,
CA).
Statistics
Data presented are mean 6 SEM. Statistical significance
(P,0.05) between multiple groups was determined using analysis
of variance (ANOVA). In whole worm studies, significance
(P,0.05) was determined using a paired Student’s t-test.
Results
Mouse heart mBK activity is insensitive to loss of Slo1
To investigate the role of Slo isoforms in conferring K
+ transport
across the mitochondrial inner membrane, a recently developed
fluorescent assay [20] was applied to isolated mouse heart
mitochondria, in which thallium (Tl
+) flux serves as a K
+
surrogate. Tl
+, unlike K
+, is not normally present in the
mitochondrial matrix and so does not require depletion prior to
the assay. In addition, Tl
+ is transported very effectively by K
+
channels. In conjunction with transporter-specific pharmacologic
signatures, this technique allows for assessment of pathways that
contribute to mitochondrial K
+ transport. For example, we
demonstrated previously that mKATP channels contribute to Tl
+
flux [20].
The mBK is a critical component of APC-mediated cardiopro-
tection [8], and to date the Slo1 gene product has been thought to
underlie mBK activity [9,10]. Under conditions where ATP was
present to block mKATP channels, we observed mitochondrial Tl
+
flux that was activated by bithionol and inhibited by paxilline
(Figure 1A), consistent with a BK channel activity [11,22].
However, Tl
+ flux was not affected by iberiotoxin, charybdotoxin
or apamin (Figure 1A). Apamin is specific for small-conductance
K
+ channels, and so this result was not surprising. However,
charybdotoxin and iberiotoxin are thought to target the canonical
BK channel Slo1, which is voltage and calcium-activated. In light
of this observation, we also tested the ability of Ca
2+ to activate the
Tl
+ transport activity and found it to be ineffective (Figure 1A).
Such Ca
2+ insensitivity has been previously reported for cardiac
mitochondrial K
+ fluxes [23]. Finally, we found that bepridil,
which targets voltage activated Ca
2+ channels and KNa channels
[22], inhibited mBK (Figure 1A). Paxilline, Ca
2+, and bepridil did
not disrupt the membrane potential (Table S1).
Based on these observations, we obtained a mouse strain
containing the Kcnma1
tm1Rwa allele targeting Slo1 (referred to
hereafter as Slo1
-/-) [15] and investigated mBK activity (biothio-
nol-activated Tl
+ transport with the above described pharmaco-
logic sensitivities) in purified heart mitochondria. The results
(Figure 1B) show an identical mBK activity and pharmacologic
profile in both Slo1
-/- and control wild-type (WT) littermates,
suggesting mBK is not Slo1-derived.
Anesthetic preconditioning of perfused mouse hearts is
insensitive to loss of Slo1
Since mBK is thought to contribute to APC, we next tested
whether Slo1 contributes to protection against IR injury by the
volatile anesthetic isoflurane. APC protection was measured in ex-
vivo perfused hearts from Slo1
-/- mice and control WT littermates.
As previously reported [24], Slo1
-/- mice exhibited a slightly lower
heart rate (Table S2). Nevertheless, both strains exhibited identical
sensitivity to baseline IR injury (infarct size, and recovery of rate x
pressure product) (Figure 2 and Table S3). Furthermore, no
difference in APC-induced protection was observed between
Slo1
-/- and WT hearts (Figure 2 and Table S3), suggesting that
protection by APC is SLO1-independent. Moreover, protection by
ischemic preconditioning (IPC) was preserved in Slo1
-/- mice
(Figure S1 and Table S3). Although these results suggest that
SLO1 channel activity is not necessary for APC or IPC, they do
not negate the idea that SLO1 may be an important pharmaco-
logic target for cardioprotection, or may be involved in other
protective mechanisms [9].
We note that APC-induced cardioprotection was ablated by
paxilline in both the Slo1
-/- and WT hearts (Figure 2), though
paxilline alone had no effect on baseline IR injury (Figure S2).
SLO-2 and Anesthetic Preconditioning
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might be involved in APC. The SLO3 channel is unlikely to
account for the observed K
+ transport activity as it is relatively
insensitive to paxilline [25] and its expression is restricted to testes.
On the other hand, both the Slo2.1 (Slick) and Slo2.2 (Slack)
mammalian Slo2 paralogues are widely expressed. Furthermore,
they have been shown to be Ca
2+ insensitive [26,27,28], which is
in agreement with the mitochondrial Tl
+ flux data (Figure 1).
SLO2 channels are instead activated by Na
+, and while this
would be an intriguing characteristic to test, using Na
+ to stimulate
Tl
+ uptake is problematic as Na
+ affects mitochondrial function.
Initial experiements with cardiac sub-cellular protein fractions
revealed an immuno-reactive band in the mitochondria using both
anti-Slo2.1 and anti-Slo2.2 antibodies that was close to the
predicted molecular weights of Slo2.1 and Slo2.2 proteins (Figure
S3). The presence of additional bands in cardiac homogenates,
however, precluded the use of these antibodies for immunohisto-
chemical protein localization in fixed tissues. Likewise, using
genetics to test the role of SLO2 in mice is complicated by the fact
that, unlike Slo1 (and Slo3), neither of the Slo2 deletion strains have
yet been reported. For this reason, we turned to the genetic model
organism C. elegans.
The slo-2 gene product contributes to anesthetic
preconditioning in C. elegans
APC is known to protect the nematode C. elegans from
subsequent hypoxic death [7], and worm orthologs of Slo1 and
Slo2 exist. Further simplifying the use of this model is the fact that
the worm slo-2 gene has not diverged into Slo2.1 and Slo2.2
paralogs. Since loss-of-function mutants of both slo-1 and slo-2 are
viable in worms, to determine which gene products are required
for APC, these mutants were tested for their ability to be
preconditioned by isoflurane. As shown in Figure 3A, APC
significantly improved the resistance of both wild-type (WT) and
slo-1 ablated worms to hypoxic stress. This result matched our
findings with the mouse Slo1 knockout model (Figure 2). However,
the loss of slo-2 largely blocked protection by APC (Figure 3A).
These results were confirmed by using a second distinct slo-2
mutant allele (Table S4). We further demonstrated that reintro-
ducing the native slo-2 gene (contained in the WRM061CF07
fosmid) into the slo-2 mutant could restore the beneficial effects of
APC (Figure 3B). A transgenic fusion of SLO-2 to either mCherry
or GFP (Figure 3C–F) was unable to rescue the mutant (data not
shown), suggesting that the ‘‘tagged’’ protein is either non-
functional or does not localize correctly. Remarkably, all strains
were protected by IPC (Figure S4) emphasizing the specificity of
slo-2 for APC-mediated protection.
Unlike several recently identified transporters whose activity is
restricted to the mitochondrial inner membrane [29,30,31] SLO-2
was not expected to localize to the mitochondria exclusively. As
has been pointed out for the mKATP channel [32], there may only
be a few molecules per mitochondrion, particularly given SLO2’s
large unitary conductance, and confocal analysis of the SLO-2
fluorescent protein fusions indicated mainly plasma membrane
Figure 1. Mouse heart mBK channel activity is independent of
Slo1. (A) Pharmacologic characterization of mBK activity in isolated WT
(C57BL/6) mouse heart mitochondria, measured using the Tl
+-flux assay.
Mitochondrial thallium (Tl
+) uptake, a surrogate for K
+ flux, was
measured using a mitochondrial matrix loaded Tl
+-sensitive fluoro-
phore, as detailed in the methods section of Supporting Information S1.
ATP was added to block the normally open mitochondrial mKATP
channel [38,20,16]. Graph shows D fluorescence upon Tl
+ addition to
media. Where indicated, the BK channel activators Ca
2+ (open bars) or
bithionol (Bt, hatched bars) were added at the concentrations indicated.
Optimal doses are shown, since higher concentrations compromised
mitochondrial function (data not shown). The mKATP inhbitors glyburide
(Gly) and 5-hydroxydecanoate (5-HD), and the K
+ channel inhibitors
paxilline (Pax), bepridil (Bep), apamin (Ap), charybdotoxin (ChTx) and
iberiotoxin (Ibtx) were present as listed below the x-axis. (B) mBK
channel activity in heart mitochondria isolated from Slo1
-/- and WT FVB
littermate mice. The baseline D fluorescence (Ctrl, set to 100%) was
2164 and 2264 arbitrary units in WT (white bars) and Slo1
-/- (gray bars)
respectively. Pharmacologic agents were present as listed below the x-
axis. Data are means 6 SEM, N.3 (N=independent mitochondria
preparations). *p,0.05 vs. ctrl, {p,0.05 vs. ATP, {p,0.05 vs. ATP+Bt.
doi:10.1371/journal.pone.0028287.g001
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confirmed that SLO2 contributes to effective APC in the worm
model, they did not rule out a role for a plasma membrane, rather
than mitochondrial, conductance in this process. This prompted
us to investigate the role of Slo isoforms in conferring K
+ transport
across the mitochondrial inner membrane in worms more directly.
mBK channel activity C. elegans requires slo-2
mBK activity was measured in isolated C. elegans mitochondria
using the same Tl
+ flux assay described above for mouse
mitochondria [16]. C. elegans mitochondria exhibited an ATP-
insensitive Tl
+ flux that was activated by the BK agonist bithionol,
insensitive to the mKATP blockers 5-hydroxydecanoate and
glyburide, and blocked by the BK channel inhibitor paxilline
and by bepridil (Figure 4). Both paxilline and bepridil did not
decrease the Tl
+ flux signal below the signal of ATP alone
(ATP+Pax, 57.8613.1; ATP+Bep, 51.7611.4). These pharmaco-
logic properties fit the profile of a classical BK channel [33,22,34].
Interestingly, unlike in mice, Ca
2+ was capable of activating the
mBK in worms (Figure 4); the slo-2 gene product in worms is
sensitive to Ca
2+ [35]. Notably, the C. elegans mBK was insensitive
to the SLO-1 inhibitors iberiotoxin and charybdotoxin as well
[11,12].
Measuring mBK activity in mitochondria from WT, slo-1 and
slo-2 mutants (Figure 5) revealed that only loss of slo-2 abolished
bithionol-stimulated Tl
+ flux. This effect could not be attributed to
a general effect on mitochondrial function, since mKATP channel
activity was not different between strains. Overall, these data
suggest that slo-2 expression contributes to both mBK conductance
and APC in C. elegans, while slo-1 is dispensable for both.
The mBK channel is activated by isoflurane, and
pharmacologic channel activation is sufficient to elicit
hypoxic protection
Currently there is no evidence for mBK activation by volatile
anesthetics. In Figure 6 we demonstrate that isoflurane caused an
increase in Tl
+ flux through the mitochondrial inner membrane in
both mice and worms. The pharmacologic characteristics of the
Figure 2. APC in mouse hearts is independent of Slo1. Perfused hearts were subjected to IR injury, APC+IR, or paxilline (Pax)+APC+IR, as
outlined in the methods section of Supporting Information S1. (A) Left-ventricular function (heart rate x pressure product, RPP) was monitored
throughout, and is expressed as % of initial value. Data for WT (white symbols) and Slo1
-/- (gray symbols) FVB littermates are shown on separate axes
for clarity. (B) Upon completion of IR protocols, hearts were sliced, fixed and stained with TTC, to delineate live (red) and infarcted (white) tissue.
Upper panel shows typical slices used for quantitation of infarct area. Lower panel shows infarct expressed as a percent of the area at risk (100% in
this global ischemia model). Data are means 6 SEM, N=5 (N=independent hearts) *p,0.05 vs. IR, {p,0.05 vs. APC+IR.
doi:10.1371/journal.pone.0028287.g002
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+ transport activity are identical to those observed for the
bithionol-activated channel in both species (i.e., blocked by
paxilline and bepredil). Furthermore, isoflurane-stimulated chan-
nel activity was ablated in mitochondria from slo-2 mutant worms
(Figure 6B).
Finally, although our results suggest that Slo2 channel opening
by volatile anesthetics is necessary for full protection by APC, we
wanted to determine whether channel opening is sufficient to
recapitulate the protective effect of APC. Thus, the pharmaco-
logic BK activator bithionol was tested for its ability to protect
Figure 3. APC in C. elegans requires slo-2. (A) C. elegans WT control (N2-Bristol), slo-1(js379)V and slo-2(nf100)X mutants were subjected to
hypoxia-reoxygenation (HR) and isoflurane APC+HR, as detailed in the methods section of Supporting Information S1. Viability is expressed as
percent of dead worms. Means 6 SEM, N.11, (N=independent trials of .100 worms per trial), *p,0.05 vs. HR. (B) HR and APC+HR of fluorescent slo-
2(nf100)X mutant C. elegans containing an extrachromasomal array derived from a mixture of a SLO-2:mCherry gene fusion and the WRM061CF07
fosmid (rnyEx112(+)) compared to their non-fluorescent siblings that had lost the array (rnyEx112(-)). Means 6 SEM, N=4 (N=independent trials of
.100 worms per trial), *P,0.05 vs. HR. (C–F) Fluorescent confocal maximum projection (C, D) and corresponding DIC (E, F) images of C. elegans
expressing SLO-2:mCherry (C, E) or SLO-2:GFP protein fusions (D, F) in neurons and muscle via the native slo-2 promoter. The white inset in panel C
shows a single confocal slice obtained close to the surface of the worm, showing clear body wall muscle plasma membrane localization of the
mCherry fusion protein.
doi:10.1371/journal.pone.0028287.g003
Figure 4. Pharmacologic characteristics of C. elegans mBK channel activity in the wildtype N2-Bristol strain. Characterization of mBK
activity in isolated WT (N2-Bristol) worm mitochondria was measured using the Tl
+-flux assay as in Figure 1. Mitochondrial Tl
+ uptake, a surrogate for
K
+ flux, was measured using a mitochondrial matrix loaded Tl
+-sensitive fluorophore, as detailed in the methods section of Supporting Information
S1. ATP was added to block the normally open C. elegans mitochondrial mKATP channel [16]. Graph shows D fluorescence upon Tl
+ addition to media.
Channel activators and inhibitors were added as defined in Figure 1, and listed below the x-axis. Data are means 6 SEM, N.4 (N=independent
mitochondria preparations). *p,0.05 vs. ctrl, {p,0.05 vs. ATP, {p,0.05 vs. ATP+Bt.
doi:10.1371/journal.pone.0028287.g004
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data indicate that bithionol pre-treatment elicits significant
protection as reflected by reduced infarct size, and enhanced
recovery of rate x pressure product (Figure 7). Moreover, the
protection afforded by bithionol pretreatment was retained in
Slo1
-/- hearts (Figure 7), confirming that the SLO1 channel is not
the physiologic target of bithionol that elicits protection. These
data suggest that opening of a BK channel, most likely
mitochondrial and derived from Slo2, is both necessary and
sufficient for cardioprotection from ischemia.
Figure 5. C. elegans mBK channel activity requires slo-2. mBK channel activity in WT (N2-Bristol; white bars), slo-1 (js379; gray bars) and slo-2
(nf100; black bars) C. elegans. The baseline D fluorescence (Ctrl, set to 100%) was 2966, 3164 and 2664 arbitrary units in WT, slo-1 and slo-2,
respectively. Pharmacologic agents were present as listed below the x-axis. Data are means 6 SEM, N.4 (N=independent mitochondria
preparations). *p,0.05 vs. ctrl, {p,0.05 vs. ATP, {p,0.05 vs. ATP+Ca
2+ or ATP+Bt.
doi:10.1371/journal.pone.0028287.g005
Figure 6. Isoflurane activation of mBK channel activity in mouse and C. elegans. Mitochondrial Tl
+ uptake was measured using a
mitochondrial matrix loaded Tl
+-sensitive fluorophore, as detailed in the methods section of Supporting Information S1. ATP was added to block the
normally open mKATP channel. Characterization of mBK channel activity in isolated mitochondria from (A) WT (C57BL/6) mouse hearts and (B) WT (N2
Bristol) and slo-2(nf100) mutant C. elegans. Graph shows D fluorescence upon Tl
+ addition to media. Where indicated, isoflurane (Iso) and the K
+
channel inhibitors paxilline (Pax) and bepridil (Bep) were present as listed below the x-axis. Data are means 6 SEM, N$3 (N=independent
mitochondria preparations). *p,0.05 vs. ctrl, {p,0.05 vs. ATP, {p,0.05 vs. ATP+Iso.
doi:10.1371/journal.pone.0028287.g006
SLO-2 and Anesthetic Preconditioning
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Several mitochondrial K
+ channel sub-types have been
implicated in protection against ischemic injury [1], yet to date
all such channels remain undefined at the molecular level. Overall,
the unique combination of genetics and pharmacologic signatures
studied herein are consistent with a conclusion that SLO2
underlies mBK activity and APC-induced protection in both C.
elegans and perhaps in mouse hearts, as well.
While the mBK channel in both C. elegans and mouse
mitochondria displayed similar pharmacological profiles, only
the C elegans channel was activated by Ca
2+. These results are
consistent with the observation that C elegans SLO-2 channels are
activated by Ca
2+, while the mammalian Slo2 ortholog is instead
activated by Na
+ [28,26], and support the hypothesis that the
mBK necessary for mitochondrial K
+ transport and APC is
derived from SLO2 in both C elegans and mice. It is interesting that
C. elegans lack a voltage-gated Na
+ channel [36]. The differing ion-
sensitivities between mammals and C. elegans Slo2 channels may
reflect underlying differences in ischemic electrolyte handling [26],
and in this respect, it is noteworthy that the Slo2 channel
characteristics appear to reflect this divergence.
It is not yet clear which mammalian SLO2 paralogue may
constitute the mBK channel. In fact, both SLO2.1 and SLO2.2
may play important roles, since the optimal sub-cellular localiza-
tion of each paralogue appears to depend on formation of
heteromers with the other [37,12]. Unfortunately, there are
currently no pharmacologic tools to distinguish between SLO2.1
and SLO2.2, and although SLO2.1 is blocked by ATP [11] this
effect is overridden by pharmacologic channel activators (similar
to mKATP[38,20]), and it is not known how SLO2 heteromer
formation impacts ATP sensitivity.
While in C. elegans slo-2 was not necessary for protection by IPC,
from the perspective of ischemia however, we find it interesting
that SLO2.2 is activated by hypercapnia and acidosis [27] both
which protect against IR injury [39,40,41]. Of particular interest is
the role of acidosis in activating SLO2 since alkalinization of the
matrix is a result of an open mitochondrial K
+ channel [42] and
represents a possible mechanism of feedback inhibition. Likewise,
the observation that both SLO2.1 and SLO2.2 channels exhibit
Figure 7. Cardioprotection by the BK activator bithionol. Perfused hearts were subjected to IR injury (from Figure 2) or Bithionol (Bt)+IR in WT
(white symbols) and Slo1
-/- (gray symbols) FVB littermate mice, as outlined in Supporting Information S1 methods. (A) Left-ventricular function (heart
rate x pressure product, RPP) was monitored throughout, and is expressed as % of initial value. (B) Upon completion of IR protocols, hearts were
sliced, fixed and stained with TTC, to delineate live (red) and infarcted (white) tissue. Upper panel shows typical slices used for quantitation of infarct
area. Lower panel shows infarct expressed as a percent of the area at risk (100% in this global ischemia model). All data are means 6 SEM, N$4
(N=independent hearts). *p,0.05 vs. IR.
doi:10.1371/journal.pone.0028287.g007
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channel activity during ischemia, in which intracellular Na
+ is
elevated [43,44]. These commonalities may warrant further
investigation into the role of SLO2.1 and SLO2.2 in IPC in a
mammalian context.
It is clear from our data that SLO1 is not required for either
APC or IPC in worms or in mice. However, our results do not
preclude the presence of SLO1 in the mitochondria or a role for
SLO1 channels in other protective paradigms. In fact, the Slo
family of K
+ channels exhibits a wide diversity of auxiliary
subunits and multimeric assemblies in different tissues [37],
yielding diverse activities, ion/second-messenger sensitivities, and
roles in cellular processes [26]. In particular, SLO1 and SLO2.2
can heteromultimerize yielding a channel with intermediate
properties [12]. For example, SLO1 channel is sensitive to
iberiotoxin and SLO2.2 is insensitive to Ca
2+ but a SLO1/
SLO2.2 heteromultimer channel is insensitive to iberiotoxin and
sensitive to Ca
2+ [12]. Thus, the tissue diversity in BK composition
may explain previous pharmacology-based studies suggesting a
Slo1-derived mBK in other tissues [10]. Similarly, slo-1 in worms is
known to regulate neurotransmitter release at the synaptic
junction [45] where it acts upstream or parallel to syntaxin [46].
Mutants in either of these genes can alter the effect of anesthetics
on behavior [46]. It is possible that slo-1 acting through this
pathway could indirectly affect mitochondrial function through
humoral neurosecretory mechanisms. However, our unpublished
results confirm observations that syntaxin mutants, like slo-1
mutants, are nevertheless able to be effectively preconditioned by
isofluorane [7].
While it is possible that mBK activation may occur directly
through anesthetic stimulation, and we have demonstrated that
mBK in isolated mitochondria are opened by isofluorane
(Figure 6), it is also possible that activation occurs indirectly via
other anesthetic targets such as protein kinases that may co-purify
with mitochondria [8,47,48]. Such activation would then stimulate
mitochondrial K
+ uptake, with subsequent protection from
ischemia occurring via downstream mechanisms that are not yet
clear. The activation of mitochondrial K
+ channels is proposed to
mediate protection via the regulation of the mitochondrial matrix
volume, decreasing mitochondrial Ca
2+ uptake and modulating
reactive oxygen species generation [4]. Through these events
activation of the mBK might block the formation of the
mitochondrial permeability transition pore and subsequent cell
death [4].
In conclusion, the slo-2 gene in worms contributes to a K
+ influx
pathway at the mitochondrial inner membrane with a nearly
identical pharmacologic sensitivity to a repertoire of activators and
inhibitors as recombinant SLO2 channels. Furthermore, slo-2 is
necessary for APC-induced protection in worms. Conversely,
SLO1 does not contribute to the mitochondrial K
+ influx pathway
studied here, nor is it required for APC or IPC in either worms or
mice. We hypothesize that given these results, Slo2 is likely the
APC-relevant channel in mice, and our results further suggest that
pharmacologic opening of Slo2 elicits protection. These results
have the potential to refocus the design of anti-ischemic
therapeutics.
Supporting Information
Figure S1 IPC in mouse hearts is independent of Slo1.
Perfused hearts were subjected to IR injury (from Figure 2) or
ischemic preconditioning (IPC)+IR, as outlined in Supporting
Information S1 methods. (A) Left-ventricular function (heart rate x
pressure product, RPP) was monitored throughout, and is
expressed as % of initial value. Data for WT (white symbols)
and Slo1
-/- (gray symbols) FVB littermates are shown on separate
axes for clarity. (B) Upon completion of IR protocols, hearts were
sliced, fixed and stained with tetrazolium chloride, to delineate live
(red) and infarcted (white) tissue. Upper panel shows typical slices
used for quantitation of infarct area. Lower panel shows infarct
expressed as a percent of the area at risk (100% in this global
ischemia model). All data are means 6 SEM, N$4 (N=inde-
pendent hearts).*p,0.05 vs. IR.
(TIF)
Figure S2 Paxilline in mouse hearts does not affect
ischemic sensitivities. Perfused hearts were subjected to IR
injury (from Figure 2) or paxilline (Pax)+IR, as outlined in
Supporting Information S1 methods. (A) Left-ventricular function
(heart rate x pressure product, RPP) was monitored throughout,
and is expressed as % of initial value. Data for WT (white symbols)
and Slo1
-/- (gray symbols) FVB littermates are shown on separate
axes for clarity. (B) Upon completion of IR protocols, hearts were
sliced, fixed and stained with tetrazolium chloride, to delineate live
(red) and infarcted (white) tissue. Upper panel shows typical slices
used for quantitation of infarct area. Lower panel shows infarct
expressed as a percent of the area at risk (100% in this global
ischemia model). All data are means 6 SEM, N=5 (N=
independent hearts).
(TIF)
Figure S3 Immunoblot analysis of SLO2 in fractionated
cardiac tissue. Homogenate from WT (C57BL/6) mouse hearts
was fractionated and the proteins were separated by SDS-PAGE.
Slo2.1 and Slo2.2 were detected by immunoblot analysis
(NeuroMab antibodies), as detailed in Supporting Information
S1 methods. Western blots for GAPDH, adenine nucleotide
translocator 1 (ANT1) and histones validated separation of the
homogenate into cytosolic, mitochondrial and nuclear fractions,
respectively.
(TIF)
Figure S4 IPC in C. elegans is independent of slo-1 and
slo-2. WT, slo-1(js379) and slo-2(nf100) mutants were subjected to
hypoxia-reoxygenation (HR) and ischemic preconditioning
IPC+HR, as detailed in the methods section of Supporting
Information S1. Viability is expressed as percent of dead worms.
Means 6 SEM, N=4 (N=independent trials of .100 worms per
trial), *p,0.05 vs. HR.
(TIF)
Table S1 Mitochondrial membrane potential is not
affected by channel modulators. Mitochondria were isolated
from WT (C57BL/6) mice and loaded with a fluorescent indicator
(TMRE 20 nM or JC-1 0.2 mg/mL) in the presence of either
Bithionol (2.5 mM), CaCl2 (25 mM), Paxilline (1 mM) or Bepridil
(10 mM). Fluorescent indicators accumulate in mitochondria in
relation to membrane potential (Dym). Following stabilization,
Dym was collapsed via addition of Dym FCCP (10 mM) resulting
in a re-distribution of the fluorescent indicator, resulting in a
decrease in fluorescence. All data are means 6 SEM, N$3 and
are not significantly different (N=independent mitochondria
isolation of $3 mouse hearts).
(PDF)
Table S2 EKG parameters of Avertin anesthetized wild-
type (WT) and Slo1
-/- littermate FVB mice. EKG was
collected as outlined in the methods. All data are means 6 SEM,
N$13 *p,0.05 vs. WT.
(PDF)
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Groups are indicated in the left column in both wild-type (WT,
top table) and Slo1
-/- (bottom table) FVB littermates. Parameters
(indicated in the top row) were measured at the time points
indicated. LVDP, left ventricular developed pressure (% of
control). Data are means 6 SEM, N$4* p ,0.05 vs. IR (60 min
Reperfusion). {p,0.05 vs. APC+IR (60 min Reperfusion).
(PDF)
Table S4 APC-dependent protection in C. elegans
requires slo-2. C. elegans WT control (N2-Bristol), slo-
1(js379)V, slo-2(nf100)X, and slo-2(ok2214)X mutants were
subjected to hypoxia-reoxygenation (HR) and isoflurane
APC+HR, as detailed in the methods section of Supporting
Information S1, and the average reduction in % death was
determined. Means 6 SEM. N2, N=28; slo-1(js379), N=12; slo-
2(nf100), N=27; slo-2(ok2214), N=4. (N= independent trials of
.100 worms per trial).
(PDF)
Supporting Information S1 Supplementary methods.
(DOC)
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